|
ALG6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.121000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.202600E-01 |
| Normal-vs-Stage2 |
8.935800E-01 |
| Normal-vs-Stage3 |
6.587600E-01 |
| Normal-vs-Stage4 |
1.798780E-01 |
| Stage1-vs-Stage2 |
5.864400E-01 |
| Stage1-vs-Stage3 |
3.011000E-01 |
| Stage1-vs-Stage4 |
1.019580E-01 |
| Stage2-vs-Stage3 |
6.255600E-01 |
| Stage2-vs-Stage4 |
1.761430E-01 |
| Stage3-vs-Stage4 |
2.793000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.000000E-01 |
| Normal-vs-AfricanAmerican |
9.596000E-01 |
| Normal-vs-Asian |
3.121200E-01 |
| Caucasian-vs-AfricanAmerican |
8.570800E-01 |
| Caucasian-vs-Asian |
1.430790E-01 |
| AfricanAmerican-vs-Asian |
1.920190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.873400E-01 |
| Normal-vs-Female |
3.344000E-01 |
| Male-vs-Female |
8.244400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.776200E-01 |
| Normal-vs-Extreme_Weight |
3.203600E-01 |
| Normal-vs-Obese |
8.545400E-01 |
| Normal-vs-Extreme_Obese |
3.620200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.038970E-01 |
| Normal_Weight-vs-Obese |
4.469000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.150600E-01 |
| Extreme_Weight-vs-Obese |
3.475200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.787200E-01 |
| Obese-vs-Extreme_Obese |
4.764600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.534400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.316000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.429600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.384790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.900400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.471800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.949820E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.378210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.196570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.364800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.533400E-01 |
| Normal-VS-Type2 PRCC |
6.545000E-01 |
| Normal-VS-KIRP CIMP |
7.158800E-01 |
| Normal-VS-Unclassified PRCC |
6.022200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.481000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.172600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.048000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.576600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.811600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.823400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.401200E-01 |
| Normal-vs-N1 |
1.350360E-01 |
| Normal-vs-N2 |
2.307800E-01 |
| N0-vs-N1 |
8.095900E-02 |
| N0-vs-N2 |
2.062600E-01 |
| N1-vs-N2 |
8.690600E-01 |
|
|
